Autolus Therapeutics plc AUTL

$ 2.27 1.12%

Quarterly report 2024-Q3
added 12-21-2024

Autolus Therapeutics plc Balance Sheet 2011-2024 | AUTL

Annual Balance Sheet Autolus Therapeutics plc

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-187 M	-358 M	-	-	-	-	-137 M	-27.9 M	-	-	-	-	-
Long Term Debt	47.9 M	19.2 M	-	-	-	285 K	-	-	-	-	-	-	-
Long Term Debt Current	5.05 M	5.04 M	-	3.59 M	2.51 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	50.6 M	23.7 M	601 K	1.03 M	758 K	-	-	-	-	-
Total Current Liabilities	44.7 M	46.4 M	28.6 M	33.6 M	25 M	21.1 M	5.03 M	-	-	-	-	-	-
Total Liabilities	264 M	192 M	92.2 M	84.2 M	48.7 M	21.6 M	6.06 M	3.49 M	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-879 M	-670 M	-521 M	-379 M	-237 M	-113 M	-47.9 M	-28.2 M	-	-	-	-	-
Total Assets	375 M	490 M	406 M	294 M	304 M	254 M	149 M	34.2 M	-	-	-	-	-
Cash and Cash Equivalents	240 M	382 M	310 M	153 M	211 M	217 M	137 M	28.1 M	-	-	-	-	-
Book Value	111 M	299 M	313 M	210 M	255 M	233 M	143 M	30.7 M	-	-	-	-	-
Total Shareholders Equity	111 M	299 M	313 M	210 M	255 M	233 M	143 M	30.7 M	10.5 M	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Autolus Therapeutics plc

	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	48.7 M	45.8 M	46.5 M	47 M	-	-	-	-	-	-	16.5 M	-	-	19.6 M	50.6 M	49.5 M	24.3 M	24.1 M	-	30 K	121 K	-	285 K	380 K	-	-	-	763 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	351 M	326 M	319 M	226 M	-	-	-	-	-	-	92.2 M	-	-	50.2 M	84.2 M	80.3 M	51.6 M	50.2 M	48.7 M	45 M	47.9 M	-	21.6 M	17.7 M	-	-	-	6.06 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.07 B	-990 M	-931 M	-801 M	-	-	-	-	-	-	-521 M	-	-	-413 M	-379 M	-336 M	-299 M	-267 M	-237 M	-196 M	-169 M	-	-113 M	-92.7 M	-	-	-	-47.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	827 M	854 M	901 M	406 M	-	-	-	-	-	-	406 M	-	-	350 M	294 M	317 M	311 M	338 M	304 M	315 M	346 M	-	254 M	273 M	-	-	143 M	149 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	657 M	706 M	759 M	256 M	308 M	343 M	-	163 M	-	-	310 M	-	-	239 M	153 M	178 M	212 M	243 M	211 M	229 M	266 M	188 M	217 M	247 M	265 M	-	129 M	137 M	-	-	-	28.1 M	-	-	-	10.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	477 M	528 M	582 M	181 M	-	-	-	-	-	-	313 M	-	-	300 M	210 M	237 M	259 M	287 M	255 M	270 M	298 M	-	233 M	255 M	-	-	143 M	143 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	477 M	528 M	582 M	181 M	229 M	267 M	-	161 M	-	-	313 M	-	-	300 M	210 M	237 M	259 M	287 M	255 M	270 M	298 M	218 M	233 M	255 M	267 M	127 M	138 M	143 M	-	-	-	30.7 M	-	-	-	10.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency